NORMEDI DANMARK ApS: Financial statements 2024
CVR: 35663290
Source: annual report 2024, Danish Business Authority
01/10/2023 – 30/09/2024
NORMEDI DANMARK ApS (CVR 35663290) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 989,540 and a net result of DKK -74,099. Equity in the 2024 report amounted to DKK 1,466,048. The solvency ratio was 64.3%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 989,540
- Profit/Loss
- DKK -74,099
- Equity
- DKK 1,466,048
- Total Assets
- DKK 2,278,536
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 990K | -74K | 1.5M | 1 |
| 2022 | - | 2.7M | 1.3M | 1.4M | 1 |
| 2021 | - | 1.6M | 474K | 637K | 1 |
| 2020 | - | 2.3M | 986K | 1.1M | 1 |
| 2019 | - | 1.7M | 624K | 677K | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
NORMEDI DANMARK ApS has published its interim report for the period January 1, 2023 to September 30, 2023.
About NORMEDI DANMARK ApS
NORMEDI DANMARK ApS is a Danish company of the type Anpartsselskab based in Herlev, founded in 2014. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named ApS STAKE NR. 5035. The management consists of Jesper Steffensen. The board consists of Michelangelo Stefani (chair), Jesper Steffensen and Joao Malagueira. The company is owned by Hologic GGO 4 Ltd. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 1,460,197 and a net result of DKK 386,079 compared with DKK -74,099 the year before. Equity in the 2025 report amounted to DKK 1,852,127.